2D Auto EF
Fast, reproducible automated ejection fraction measurement for LV assessment
Software · EmbeddedCompany source
Company profile
About Philips Ultrasound
Philips Ultrasound is a division of Koninklijke Philips N.V. that develops advanced AI-powered ultrasound imaging solutions for cardiovascular and other clinical applications. The company's ultrasound AI solutions integrate into everyday clinical workflows to augment clinician skills while maintaining ultimate decision responsibility with healthcare providers. Fueled by high-quality training data sets, their AI innovations reduce cognitive burden and drive productivity through automated image formation, acquisition, measurement, and reporting. The flagship EPIQ CVx premium cardiovascular ultrasound system features powerful AI-based capabilities including AutoStrain LV with automated ejection fraction and strain quantification, SmartView Select for automatic optimal image selection, and 3D Auto Color Flow Quantification for mitral regurgitation assessment. These features eliminate the need for manual view selection and visual analysis, helping reduce variability between users and supporting expanded use of ultrasound across healthcare settings. Philips Ultrasound serves cardiology departments, echocardiography labs, and interventional procedure suites in health systems worldwide, providing solutions for both transthoracic and transesophageal echocardiography.
Company description Philips Ultrasound official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Work at Philips Ultrasound?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiac structural abnormalities
- Congenital heart disease
- Left ventricular dysfunction
- Mitral regurgitation
- Tricuspid valve disease
Who it serves
- Cardiology departments
- Echocardiography labs
- Health Systems
- Interventional procedure suites
Deployment & integration
Embedded · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: Multi-vendor ultrasound data support, TOMTEC-ARENA platform.
Geographic context
MarketsGlobal markets · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launch of X11-4t mini TEE transducer, AutoStrain LV with 2D automated EF and mid-layer strain, SmartView Select AI technology
Partnerships
Recorded partners
- DiA Imaging analysis (Philips company)
- TOMTEC-ARENA platform
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
3D Auto Color Flow Quantification
AI-powered automatic color flow quantification for mitral regurgitation assessment
Software · EmbeddedCompany source
3D Auto Tricuspid Valve Quantification
AI-driven tricuspid valve quantification to guide device selection
Software · EmbeddedCompany source
Auto Segmental Wall Motion Scoring
Automated evaluation of wall motion in standard 17-segment bullseye display
Software · EmbeddedCompany source
AutoStrain LV
Fast, reproducible 2D strain quantification with automated EF and mid-layer strain
Software · EmbeddedCompany source
EPIQ CVx
Premium cardiovascular ultrasound system with AI-based capabilities and advanced diagnostics
Device · On PremiseCompany source
EPIQ CVxi
Premium cardiovascular ultrasound system for interventional echocardiography
Device · On PremiseCompany source
Philips Ultrasound AI Solutions
AI-powered ultrasound solutions for intuitive, reproducible imaging across users and scans
Software · EmbeddedCompany source
SmartView Select
AI-based software for preselection and analysis of optimal apical cardiac ultrasound views
Software · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · Sep 1, 2026
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · Sep 1, 2026
Ultrasound Cavitation of Microbubbles Augments Limb Perfusion and Promotes Ulcer Healing in Chronic Limb-Threatening Ischemia.JACC. Cardiovascular imaging · Aug 4, 2026
Aberration correction in fetal ultrasound: Clinical evaluation on image quality improvement.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · Jun 30, 2026
Ultrasound cavitation therapy: inducing tumor drug delivery and blood flow changes with clinical ultrasound tools.Journal of controlled release : official journal of the Controlled Release Society · May 10, 2026
Influence of Microbubble Properties and Carrier Frequency on Ultrasound Cavitation-Induced Flow Augmentation.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · Feb 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
EPIQ Series Diagnostic Ultrasound System, Affiniti Series Diagnostic Ultrasound SystemK253595 · 510k · Mar 27, 2026
Lumify Diagnostic Ultrasound SystemK252557 · 510k · Dec 22, 2025
EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound SystemK251651 · 510k · Oct 9, 2025
EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound SystemK251455 · 510k · Jul 24, 2025
EPIQ Series Diagnostic Ultrasound Systems; Affiniti Series Diagnostic Ultrasound SystemsK250886 · 510k · Jun 18, 2025
EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound SystemK243793 · 510k · May 21, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Reproducibility
Fast, easy and reproducible mitral regurgitation volume assessment
Workflow efficiency
Automated EF and strain quantification improving workflow and saving time
Variability reduction
Reduces variability between users through automated view selection and analysis
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Philips Ultrasound
Recent articles published on Philips Ultrasound's official website.
Press release | August 06, 2026Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
Read on Philips UltrasoundPress release | June 29, 2026University Health in San Antonio selects Philips enterprise monitoring platform to transform patient monitoring and advance system-wide standardization as patient volume grows
Read on Philips UltrasoundPress release | June 09, 2026AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
Read on Philips UltrasoundMedia updates: Philips Respironics voluntary June 2021 recall notification
Read on Philips UltrasoundJust launched
Read on Philips Ultrasound07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.